» Articles » PMID: 1790159

Brain Gamma-aminobutyrate Transaminase and Monoamine Oxidase Activities in Suicide Victims

Overview
Specialties Neurology
Psychiatry
Date 1991 Jan 1
PMID 1790159
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The activity of gamma-aminobutyrate amino-transferase (GABA-T) and monoamine oxidase (MAO-A and -B) was measured in 42 postmortem human brains. Three brain regions (frontal cortex, cingulate cortex and hypothalamus) from 23 controls without known neurological or psychiatric disorder and from 19 suicide victims were analysed. The suicide victims were classified according to the use of violent and non-violent methods and to the presence or absence of a known history of depressive disorder. No difference was found between the series of suicide victims and the control subjects with regard to GABA-T activity. Carbon monoxide poisoning and death by drug overdose, however, were found to reduce the activity. The MAO-B activity did not differ between the groups. With MAO-A, however, a significant elevation (t = 2.01; P less than 0.05) was found in the hypothalamic region of the suicide victims. The difference seemed to be confined to the subgroup of suicides with a record of depressive disorder.

Citing Articles

Molecular Targets of Cannabinoids Associated with Depression.

Paudel P, Ross S, Li X Curr Med Chem. 2021; 29(11):1827-1850.

PMID: 34165403 PMC: 9007087. DOI: 10.2174/0929867328666210623144658.


Evidence revealing deregulation of the KLF11-MAO A pathway in association with chronic stress and depressive disorders.

Harris S, Johnson S, Duncan J, Udemgba C, Meyer J, Albert P Neuropsychopharmacology. 2014; 40(6):1373-82.

PMID: 25502632 PMC: 4397395. DOI: 10.1038/npp.2014.321.


Pharmacoepigenetics of depression: no major influence of MAO-A DNA methylation on treatment response.

Domschke K, Tidow N, Schwarte K, Ziegler C, Lesch K, Deckert J J Neural Transm (Vienna). 2014; 122(1):99-108.

PMID: 24809685 DOI: 10.1007/s00702-014-1227-x.


The role of the serotonergic system in suicidal behavior.

Sadkowski M, Dennis B, Clayden R, ElSheikh W, Rangarajan S, DeJesus J Neuropsychiatr Dis Treat. 2013; 9:1699-716.

PMID: 24235834 PMC: 3825712. DOI: 10.2147/NDT.S50300.


The reduction of R1, a novel repressor protein for monoamine oxidase A, in major depressive disorder.

Johnson S, Stockmeier C, Meyer J, Austin M, Albert P, Wang J Neuropsychopharmacology. 2011; 36(10):2139-48.

PMID: 21654740 PMC: 3158311. DOI: 10.1038/npp.2011.105.


References
1.
Markwell M, Haas S, Bieber L, Tolbert N . A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978; 87(1):206-10. DOI: 10.1016/0003-2697(78)90586-9. View

2.
Cheetham S, Crompton M, Katona C, Parker S, Horton R . Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims. Brain Res. 1988; 460(1):114-23. DOI: 10.1016/0006-8993(88)91211-5. View

3.
Roy A, Virkkunen M, Linnoila M . Reduced central serotonin turnover in a subgroup of alcoholics?. Prog Neuropsychopharmacol Biol Psychiatry. 1987; 11(2-3):173-7. DOI: 10.1016/0278-5846(87)90056-x. View

4.
Schwarcz R, Bennett Jr J, Coyle J . Inhibitors of GABA metabolism: implications for Huntington's disease. Ann Neurol. 1977; 2(4):299-303. DOI: 10.1002/ana.410020407. View

5.
Gold B, BOWERS Jr M, Roth R, Sweeney D . GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry. 1980; 137(3):362-4. DOI: 10.1176/ajp.137.3.362. View